Search
for
Sort by
Research 301–330 of 1000+
- The stag as an historical source of materia medica
- Effect of decellularisation methods on methacryloyl-substituted placental ECM hydrogels
- Skin Disorders in Athletes: Professional and Recreational Sports
- Contents list
- The in vitro plasticity of hair follicle dermal and mesenchymal stem cells
- Book Reviews
- ANNOUNCEMENTS
- Scanning Electron Microscopic Study on Collagen Fibrils in the Mink Dermis during the Hair Cycle and Growth
- The Neurobiology of Sexual Function
- Polycystic Ovary Syndrome
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Drug-Induced Skin, Nail and Hair Disorders
- Melanocytes: The new Black
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- TOXIC EPIDERMAL NECROLYSIS
- Idiopathic Hirsutism*
- 5α-Reduced glucocorticoids: a story of natural selection
- How to Speak Postmodern: Medicine, Illness, and Cultural Change
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- MOUSE MODELS FOR THE STUDY OF HUMAN HAIR LOSS
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Pregnancy and Skin
- Is polycystic ovary syndrome a sexual conflict? A review
- An Update on Drug-Induced Pigmentation
- The dermatological consequences of obesity
- Novel inhibitors of 5α-reductase